| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 88,317 | 87,541 | 89,536 | 107,403 | | Cost of Revenue | 53,097 | 55,438 | 55,229 | 69,619 | | | Gross Profit | 35,220 | 32,103 | 34,307 | 37,784 | | | Operating Expenses | | Research Development | 9,339 | 9,010 | 9,355 | (35,125) | | Selling General and Administrative | 27,942 | 26,711 | 27,487 | 30,430 | | Non Recurring |
-
| 4,070 |
-
| 166,012 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,346) | (7,688) | (2,535) | (123,533) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,610) | 210 | 237 | 10,639 | | Earnings Before Interest And Taxes | (8,940) | (7,478) | (2,298) | (112,894) | | Interest Expense | (4,770) | 2,414 | 2,356 | 1,442 | | Income Before Tax | (4,170) | (9,892) | (4,654) | (114,336) | | Income Tax Expense | (652) | (749) | 164 | 26,401 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,518) | (9,143) | (4,818) | (140,737) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,518) | (9,143) | (4,818) | (140,737) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,518) | ($9,143) | ($4,818) | ($140,737) |
|
0.02% Nasdaq 
0.44%
Income Statement
